QTRX
Quanterix Corporation
QTRX's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over QTRX overall, supported by lower modeled downside and stronger fundamentals.
QTRX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Unavailable |
QTRX's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
QTRX PE Valuation
QTRX has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
QTRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect QTRX's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
QTRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.35 | -$0.02 |
| Q2 2026 | -$2.62 | -$0.80 |
| Q1 2026 | -$2.35 | -$1.11 |
| Q4 2025 | -$2.51 | -$1.51 |
| Q3 2025 | -$2.33 | -$1.40 |
| Q2 2025 | -$1.82 | -$0.90 |
| Q1 2025 | -$1.24 | -$0.35 |
| Q4 2024 | -$1.00 | -$0.24 |
QTRX lost $2.35 per share over the past year, about the same as its loss the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over QTRX on earnings quality, reporting a profit while its opponent remains loss making.
QTRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35M | -13% |
| Q2 2026 | $32.9M | +34% |
| Q1 2026 | $36.4M | +20% |
| Q4 2025 | $43.9M | +25% |
| Q3 2025 | $40.2M | +12% |
| Q2 2025 | $24.5M | -29% |
| Q1 2025 | $30.3M | -5.4% |
| Q4 2024 | $35.2M | +11% |
QTRX's revenue is growing: $35M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -64% | +29 points |
| Q2 2026 | -150% | +1.4 points |
| Q1 2026 | -114% | -27 points |
| Q4 2025 | -56% | -14 points |
| Q3 2025 | -93% | -60 points |
| Q2 2025 | -152% | -120 points |
| Q1 2025 | -87% | -40 points |
| Q4 2024 | -42% | +1.2 points |
QTRX's operating margin was −64% last quarter, up 28 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over QTRX on profitability, with a higher operating margin.
QTRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.3M | +$25.6M |
| Q2 2026 | -$5.2M | +$1.2M |
| Q1 2026 | -$18.2M | -$3.1M |
| Q4 2025 | -$16.3M | -$11.6M |
| Q3 2025 | -$41.9M | -$35.3M |
| Q2 2025 | -$6.4M | +$118K |
| Q1 2025 | -$15.1M | +$5.5M |
| Q4 2024 | -$4.7M | +$3.4M |
QTRX has burned cash in almost every quarter: −$56M over the past year, against −$68M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over QTRX on cash generation, producing positive trailing cash flow while its opponent burns cash.
QTRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +221K shares |
| 1 year | +2.9% | +1.3M shares |
| 3 years | +26% | +9.7M shares |
| 5 years | +30% | +10.9M shares |
| Available history | +69% | +19.4M shares |
QTRX has 47M diluted shares, up 2.9% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over QTRX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
QTRX Net Leverage
QTRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
QTRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 39.4 | Neutral |
QTRX's weekly RSI is 43 (neutral) and its Stochastic is 39 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
QTRX PE vs Healthcare Sector
QTRX has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
QTRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.07 | 6.8% below |
| 20 week MA | $3.22 | 11% below |
| 50 week MA | $4.24 | 33% below |
| 100 week MA | $5.37 | 47% below |
| 200 week MA | $11.9 | 76% below |
QTRX is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over QTRX on trend strength, trading above more of its moving averages.
QTRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.5 | $45.9 | +95% |
| 2021 | $45.9 | $43.9 | -4.5% |
| 2022 | $43.9 | $12.9 | -71% |
| 2023 | $12.9 | $27.3 | +112% |
| 2024 | $27.3 | $11.1 | -60% |
| 2025 | $11.1 | $6.46 | -42% |
| 2026 YTD | $6.46 | $2.86 | -56% |
QTRX's yearly returns have swung widely, from +112% in 2023 to −71% in 2022. It's down 56% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over QTRX on returns for 2026, with the stronger performance.